Commercial Funding Opportunities
The National MS Society is committed to accelerating breakthroughs to fuel treatments and solutions that will stop disease progression, restore function, and end multiple sclerosis (MS) forever. As an important part of the Society’s research infrastructure, investments through Fast Forward will continue to close the gap between promising discoveries and the commercial development necessary to get new treatments to people with MS. Read more about what Fast Forward funds, and whom they have funded.
For more information, please contact:
Mark Allegretta, PhD
Associate Vice President, Commercial Research
Director, Business and Partnership Development
Walter Kostich, PhD
Director, Commercial Research